Lance E. Thibault - 16 May 2023 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Chief Financial Officer
Signature
/s/ Matthew P. Blischak, Attorney-in-Fact
Issuer symbol
FNCH
Transactions as of
16 May 2023
Net transactions value
$0
Form type
3
Filing time
16 May 2023, 16:05:22 UTC
Previous filing
03 Feb 2022
SEC
View on sec.gov

Key filing fact

Lance E. Thibault filed Form 3 for Finch Therapeutics Group, Inc. (FNCH) on 16 May 2023.

Key facts

  • This page summarizes Lance E. Thibault's Form 3 filing for Finch Therapeutics Group, Inc. (FNCH).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 16 May 2023, 16:05.

Change

  • Previous filing in this sequence was filed on 03 Feb 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC Source

Ownership activity is grounded in SEC Form 3 disclosures.

See Original Filing

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .